Introduction
============

As the most economical energy source, carbohydrates are now being commonly incorporated into aquafeeds to improve the physical quality of the feed and reduce the catabolism of proteins and lipids by aquatic animals ([@B77]). However, it is generally acknowledged that fish show poor capability in utilizing carbohydrates for energy purposes than terrestrial animals ([@B28]; [@B16]). Furthermore, most species (especially carnivorous ones) often exhibit prolonged hyperglycemia after an intake of carbohydrate-enriched diets or a glucose load ([@B50]; [@B36]) as is similar to the symptoms of type 2 diabetes mellitus observed in mammals. Previous studies have suggested that the poor carbohydrate utilization or the persistent hyperglycemia in fish may be attributed to the relatively low number of insulin receptors, the low affinity of glucose transporter proteins for glucose, a poor inhibition of postprandial gluconeogenesis, poor hepatic lipogenesis from glucose, etc ([@B51]; [@B16]). Recently, several approaches such as metabolomics and transcriptomics are being employed to assess diet-induced metabolic syndromes in fish ([@B48]; [@B56]; [@B57]). Findings from such studies suggest that the disruption of the energy homeostasis in fish is closely implicated in the development of disturbances in the glucose metabolism. Therefore, further biochemical and molecular investigations of the energy metabolism are necessary and will undoubtedly facilitate better understanding of the utilization of carbohydrates by fish.

In eukaryotes, the mitochondria are regarded as the most important organelles responsible for cellular ATP synthesis and metabolism ([@B65]). Mitochondrial function mainly depends on the mitochondrial content and shape ([@B68]). Generally, increased mitochondrial content has been observed in response to challenges involving high-energy demands, such as in electrical stimulation, exercise, cold, heat, stress, etc. ([@B5]; [@B10]; [@B8]; [@B22]). Mitochondrial biogenesis is a complex and precise process involving the replication of mitochondrial DNA (mtDNA) and the expression of nuclear and mitochondrial genes ([@B68]). In this regard, adenosine monophosphate (AMP)-activated protein kinase (AMPK), known as the cellular "fuel gauge," may play a central role, since the energy homeostasis mediated by it is closely related to the biosynthesis and function of mitochondria ([@B80]). Also, the AMPK can be activated by a variety of metabolic stresses that typically increase the cellular AMP/ATP ratio, such as hypoxia, exercise, a glucose load, energy restriction, and so on ([@B26]). Once activated, AMPK phosphorylates the mitochondrial master regulator: peroxisome proliferator-activated receptor γ coactivator-1 (especially PGC-1α and PGC-1β isoforms) ([@B60]; [@B7]). Subsequently, the phosphorylated PGC-1 activates the nuclear respiratory factor-1 (NRF-1), which, in turn, regulates the expressions of both mitochondrial and nuclear genes encoding respiratory chain subunits and other proteins that are responsible for mitochondrial biogenesis and function ([@B72]; [@B68]). However, these activities have been mainly observed in mammals. Relevant information in fish has been quite limited until now. Recently, some differences have been identified between fish and mammals related to the mitochondrial biogenesis pathway. Accordingly, PGC-1β has been demonstrated to be more effective than PGC-1α when the mitochondrial gene expression was observed, although they have similar capabilities to induce mitochondrial biogenesis in mammals ([@B7]). In addition, the mitochondrial function in fish also has been reported to be affected by a large number of factors, including genetics, growth and/or developmental stages, water temperature, diet composition, etc. ([@B40]; [@B17], [@B18], [@B19]; [@B43]). However, information concerning carbohydrate metabolism is still unknown. Considering this, it is of great significance to investigate the potential effects of high-carbohydrate (HC) feeding on the mitochondrial function of fish and characterize the underlying mechanisms. This might facilitate the discovery of effective approaches to improve the mitochondrial function in fish as well as open a new approach to promote its carbohydrate utilization.

Mitochondrial dysfunction is a crucial triggering factor of metabolic diseases such as insulin resistance and diabetes ([@B37]; [@B52]). At present, accumulating evidence has indicated that the supplementation of mitochondrial nutrients (mt-nutrients) could bring about a series of physiological benefits on mitochondrial structure and function, such as (1) the improvement of mitochondrial membrane structure; (2) the enhancement of mitochondrial enzymes activities by elevating cofactors levels; (3) increase in antioxidant defenses by scavenging excess of free radicals, and so on ([@B45]). Among these mt-nutrients, vitamin B~1~ has attracted considerable attention as it can serve as the essential cofactor to regulate the activity of various mitochondrial enzymes, thereby, improving intracellular mitochondrial function ([@B14]). However, vitamin B~1~ is excreted quickly from the body due to its water-soluble characteristic, which can lead to a reduction in its biological functions ([@B3]). Benfotiamine is a lipid-soluble analog of vitamin B~1~ with higher absorption and bioavailability than vitamin B~1~, and is commonly used as a food supplement for the treatment of diabetic complications ([@B3]). It can improve glucose homeostasis by blocking three major pathways associated with hyperglycemic damage: the hexosamine, the advanced glycation end products (AGEs) formation, and the diacylglycerol (DAG)--protein kinase C pathways ([@B25]). In addition, benfotiamine administration can remarkably enhance the activity of dehydrogenase enzyme complexes by increasing intracellular thiamine diphosphate (TPP) levels, thereby increasing glucose oxidation in mitochondria ([@B21]). Moreover, benfotiamine also has been demonstrated to be able to alleviate the stress caused by the overproduction of superoxide anion in the mitochondrial electron transport chain ([@B11]). Despite the fact that significant improvements of mitochondrial function have been confirmed in mammals, such information in aquatic animals is extremely scarce. Whether benfotiamine can improve the glucose homeostasis in fish through the enhancement of mitochondrial function still needs to be elucidated.

Blunt snout bream (*Megalobrama amblycephala*) is a commercially important freshwater fish in China ([@B73]). Due to its herbivorous feeding habits, diets formulated for this fish usually contain large proportions of carbohydrates to reduce the feed cost and maximize the profit. However, severe metabolic burden coupled with the compromised glucose homeostasis is usually observed in this species after the feeding of HC diets ([@B42]). Previously, our study had demonstrated that long-term administration of benfotiamine at 2.85 mg/kg could significantly improve the glucose homeostasis of this species being fed HC diets. However, the underlying mechanisms are still poorly understood. In addition, the growth performance was slightly compromised, suggesting that this dosage might be too high for this species ([@B74]). Hence, we speculated that (1) a dose-dependent effect of benfotiamine might exist on the growth performance and intermediary metabolism of fish and (2) benfotiamine might benefit the glucose homeostasis of fish through the promotion of mitochondrial function. Bearing these facts in mind, the present study was conducted to (1) evaluate the effects of different dietary levels of benfotiamine on the growth performance, tissue glycogen and lipid deposition, and levels of plasma metabolites in juvenile blunt snout bream fed an HC diet and (2) investigate its beneficial effects on mitochondrial biogenesis and function in the liver of this species of fish. The findings obtained here might provide us with some new insights into carbohydrate metabolism in fish as well as facilitate the development of nutritional strategies to improve the carbohydrate utilization by aquatic animals.

Materials and Methods {#s1}
=====================

Ethics Statement
----------------

The care and use of animals in the present study followed the ethical guidelines of the Nanjing Agriculture University in China \[permit number: SYXK (Su) 2011-0036\]. All experimental procedures involving animals were conducted following the Guidelines for the Care and Use of Laboratory Animals in China.

Benfotiamine and Diets
----------------------

Benfotiamine was obtained from Xian Reain Biomedical Company (Xian, China) with a purity of at least 98%. Six isonitrogenous and isolipidic diets were formulated, including a control diet (30% carbohydrate, C), an HC diet (43% carbohydrate), and the HC diet supplemented with different benfotiamine levels \[0.7125 (HCB1), 1.425 (HCB2), 2.85 (HCB3), and 5.7 (HCB4) mg/kg, respectively\]. Dietary carbohydrate levels were adopted according to our previous studies ([@B42]). Feed formulation and proximate composition of the experimental diets are presented in **Table [1](#T1){ref-type="table"}**. Proteins were derived from fish meal, soybean meal, rapeseed meal, and cottonseed meal. Dietary lipids were derived from fish oil and soybean oil. Corn starch was adopted to meet the dietary carbohydrate levels required. Microcrystalline cellulose was included as the filler.

###### 

Formulation and proximate composition of the experimental diets.

                                                  C       HC      HCB1     HCB2    HCB3    HCB4
  ----------------------------------------------- ------- ------- -------- ------- ------- -------
  **Formulation (%)**                                                                      
  Fish meal                                       8.00    8.00    8.00     8.00    8.00    8.00
  Soybean meal                                    26.00   26.00   26.00    26.00   26.00   26.00
  Rapeseed meal                                   17.00   17.00   17.00    17.00   17.00   17.00
  Cottonseed meal                                 17.00   17.00   17.00    17.00   17.00   17.00
  Fish oil                                        2.00    2.00    2.00     2.00    2.00    2.00
  Soybean oil                                     2.00    2.00    2.00     2.00    2.00    2.00
  Corn starch                                     12.00   25.00   25.00    25.00   25.00   25.00
  Benfotiamine (mg/kg)                            0       0       0.7125   1.425   2.85    5.7
  Microcrystalline cellulose                      13.00   0.00    0.00     0.00    0.00    0.00
  Calcium biphosphate                             1.80    1.80    1.80     1.80    1.80    1.80
  Premix^∗^                                       1.20    1.20    1.20     1.20    1.20    1.20
  **Proximate composition (% *air-dry basis*)**                                            
  Moisture                                        6.96    6.85    6.92     6.95    6.90    6.87
  Crude lipid                                     5.93    5.71    5.78     5.66    5.77    5.87
  Ash                                             8.46    8.28    8.12     8.23    8.34    8.20
  Crude protein                                   29.82   30.12   30.31    30.03   30.02   30.11
  Crude fiber                                     16.97   6.18    6.29     6.30    6.23    6.28
  Nitrogen-free extract^†^                        31.86   42.75   42.58    42.83   42.74   42.67
  Energy (MJ/kg)                                  19.09   19.24   19.38    19.31   19.23   19.30
                                                                                           

C, the control diet; HC, the high-carbohydrate diet; HCB1, the HC diet supplemented with 0.7125 mg/kg benfotiamine; HCB2, the HC diet supplemented with 1.425 mg/kg benfotiamine; HCB3, the HC diet supplemented with 2.85 mg/kg benfotiamine; HCB4, the HC diet supplemented with 5.7 mg/kg benfotiamine (the same below).
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Calculated by difference (100 - moisture - crude protein - crude lipid - ash - crude fiber).

Animals, Experimental Conditions, and Sampling
----------------------------------------------

Juvenile blunt snout bream were purchased from the National Fish Hatchery Station in Yangzhou (Jiangsu, China). Before the experiment, fish were acclimatized to the experimental conditions for 2 weeks, during which they were fed a commercial diet (32% protein, 6% lipids, and 33% carbohydrates) to apparent satiation, manually, three times daily. After acclimatization, 360 fish of similar size (average weight: 45.25 ± 0.34 g) were randomly distributed among 24 indoor tanks (300 L volume) at a number of 15 fish per tank. Fish in each tank were randomly fed with one of the six experimental diets. Each diet was tested in four tanks. Fish were fed to visual satiation thrice daily (07:00, 12:00, and 17:00 h) for 12 weeks. Throughout the experimental period, water temperature averaged 27.4 ± 0.6 °C, pH 7.4--7.5, photoperiod 12: 12 h (dark: light), and dissolved oxygen was maintained above 5.0 mg/L.

After the last meal, all the fish in each tank were fasted for 24 h to empty gut content, and then counted and weighed. Subsequently, 4 fish from each tank were randomly selected and anesthetized with MS-222 (tricaine methanesulfonate; Sigma, United States) at 100 mg/L. Blood was drawn into heparinized tubes as described by [@B75]. Liver, muscle, and adipose tissue were removed and immediately frozen in liquid N~2~, and then stored at -80°C until assayed.

Analysis of Proximate Composition, Plasma and Liver Metabolites, and Tissue Glycogen and Lipid Contents
-------------------------------------------------------------------------------------------------------

The proximate composition of diets was determined as follows: dry matter by drying in an oven at 105°C to a constant weight; protein content (nitrogen × 6.25) using the Kjeldahl method after acid digestion (FOSS KT260, Höganäs, Sweden); crude lipid content by ether extraction in a Soxtec System HT (Soxtec System HT6, Tecator, Höganäs, Sweden); ash by incineration in a muffle furnace at 550°C for 4 h; gross energy content by an adiabatic bomb calorimeter (PARR 1281, United States), and crude fiber was determined by the fritted glass crucible method using an automatic analyzer (ANKOM A2000i, United States).

Plasma glucose level was determined using the glucose oxidase method ([@B2]). Plasma glycated serum protein (GSP) and AGEs levels were assayed by the method detailed by [@B13] and [@B49], respectively. Plasma insulin level was measured using a heterologous radioimmunoassay method using bonito (*Thunnus thynnus*) insulin as the standard and rabbit antibonito insulin as antiserum ([@B24]). This method has been confirmed in *Cyprinus carpio* ([@B30]), which shares the same classification (Cyprinidae family) with *M. amblycephala*. Hepatic contents of adenosine triphosphate (ATP) and AMP were assessed as described by [@B33] and [@B46], respectively. Tissue glycogen and lipid contents were analyzed following the methods detailed by [@B20] and [@B38], respectively.

Analysis of Mitochondrial Respiratory Chain Complex Enzyme Activities
---------------------------------------------------------------------

Liver mitochondria isolation was performed using a commercial kit (G006, Nanjing Jiancheng Bioengineering Institute, Nanjing, China). Briefly, after the last meal, fresh liver samples were obtained from another tank with 4 fish, and were then placed immediately in the ice-cold extraction medium consisting of 10 mM KH~2~PO~4~, 250 mM sucrose, and 5 mM ethylenediaminetetraacetic acid. Subsequently, 1 g of liver tissue was homogenized in 10 mL of cold medium. The homogenates were spun down for 10 min at 1,500 *g* in a refrigerated centrifuge. The supernatants were retained in a new centrifuge tube. For the preparation of the mitochondrial fraction, the remaining supernatants were centrifuged by a second spin. The sediment was washed three times with the previously mentioned medium, and was then resuspended in a small volume of medium plus fatty acid-free bovine serum albumin (1 mg/mL). The mitochondrial suspensions were immediately stored at -80°C for subsequent analysis. Mitochondrial protein concentration was determined using the method of [@B6]. The activities of complex I--III were measured following the methods detailed by [@B34]. Furthermore, complex IV and V activities were analyzed following the methods of [@B39].

Western Blot and Quantitative Polymerase Chain Reaction (qPCR) Analysis
-----------------------------------------------------------------------

Hepatic protein extraction was performed according to our previous study ([@B76]). Subsequently, protein lysates (20 μg of protein) were separated on a sodium dodecyl sulfate--polyacrylamide gel electrophoresis gel using a Mini-PROTEAN system (BioRad, Spain) for 1--2 h at 100 V. Then, the electroblotted proteins were transferred to a polyvinylidene difluoride (PVDF) membrane (Millipore Corp., Bedford, MA, United States). The specific primary antibodies used were anti-β-actin (BM3873, Boster, China, 1:5000 dilution), anti-AMPKα (\#2532, Cell Signaling Technology, United States, 1:2000 dilution), anti-phospho-AMPKα (\#2535, Cell Signaling Technology, United States, 1:2000 dilution), anti-PGC-1β (22378-1-AP, Proteintech, United States, 1:1000 dilution), and anti-NRF1 (ab34682, Abcam, Cambridge, MA, United States, 1:1000 dilution). After washing, PVDF membranes were incubated with anti-rabbit (\#7074, Cell Signaling Technology, United States, 1:2000 dilution) and anti-rabbit (BA1054, Boster, China, 1:50,000 dilution) secondary antibodies, respectively. Immune complexes were detected by a chemiluminescent substrate (Gel Imagine CHEMI-SMART-3126, France) based on the manufacturer's instructions, and visualized with a luminescent image analyzer (Fujifilm LAS-3000, Japan). The protein levels were normalized by β-actin, and the intensities of each lane were quantified using the densitometry band analysis tool in Image J 1.44p (U.S. National Institutes of Health, Bethesda, MD, United States).

Total RNA extraction and cDNA synthesis were performed using the liver samples according to our previous studies ([@B74], [@B76]). Briefly, the quantity and purity of isolated RNA were determined by absorbance measures at 260 and 280 nm, and its integrity was tested by electrophoresis in 1.0% formaldehyde denaturing agarose gels. Specific primers for PGC-1β, NRF-1, Mfn-1, Mfn-2, Opa-1, Drp-1, Fis-1, Mff, and uncoupling protein (UCP)-2 were designed using primer premier 5.0 based on the partial cDNA sequences of the target genes using the transcriptome analysis of blunt snout bream ([@B23]). The AMPKα-1, AMPKα-2, TFAM, ND-1, CYT B, COX-1, COX-2, and ATP-6 were designed using the published sequences of blunt snout bream (**Table [2](#T2){ref-type="table"}**). All primers were synthesized by Invitrogen BioScience & Technology Company (Shanghai, China). Subsequently, the real-time qPCR was run on an ABI 7500 real-time PCR system (Applied Biosystems, Carlsbad, CA, United States) using the SYBR Green II Fluorescence Kit (Takara Bio. Inc., Japan). The fluorescent quantitative PCR reaction solution consisted of 2.00 μL template (equivalent to 500 ng cDNA), 10.00 μL SYBR^®^ premix Ex Taq^TM^ (2×), 0.40 μL Rox Reference Dye II, 0.40 μL PCR Forward Primer (10 μM), 0.40 μL PCR Reverse Primer (10 μM), and 6.80 μL dH~2~O. The qPCR consisted of 40 cycles with the first step of denaturation at 95°C for 30 s and a final extension of 95°C for 5 s and annealing at 60°C for 34 s. All amplicons were initially separated by agarose gel electrophoresis to ensure that they were of the correct size. Finally, the relative transcripts of target mRNA were analyzed by elongation factor 1 α (EF1α) gene using the 2^-ΔΔCT^ method.

###### 

Nucleotide sequences of the primers used to assay gene expressions by real-time PCR.

  Target gene   Forward (5′-3′)         Reverse (5′-3′)        Accession numbers or reference
  ------------- ----------------------- ---------------------- --------------------------------
  AMPKα-1       AGTTGGACGAGAAGGAG       AGGGCATACAAAATCAC      ARF07712.1
  AMPKα-2       ACAGCCCTAAGGCACGATG     TGGGTCGGGTAGTGTTGAG    KX061841
  PGC-1β        GTGAGGAACGGGGAGATTG     AGGGGGGTGAACAGGAAAC    [@B23]
  NRF-1         CACAAGCCCTGAGGACTA      ACCTGTATGAGCGAGACG     [@B23]
  TFAM          TCCGAAAGTTAGCAGAGA      ATGAAGATGTTGAAGGCG     KT380498.1
  Mfn-1         CTCCAGATGCTCATTCCCT     TTCCTTGGCTTTGGTTGTC    [@B23]
  Mfn-2         ACGCCTCTCCGCTCAAACAC    CTTCCCCAATCCCTGCCACT   [@B23]
  Opa-1         CTTGTTGACTTGCCTGG       TTCATTACGGATGTGCT      [@B23]
  Drp-1         CAGAGGGACTGCGAGGTT      GGCTTGAGCAAAAGGGAA     [@B23]
  Fis-1         ATACAAGCAAAAAAGACGAT    ATACAAAATAAAAAAAGGGG   [@B23]
  Mff           CCCGAGAGAATCGTAGTGG     GGCGTCTTGAGGGACAGTG    [@B23]
  ND-1          CTGACCACTAGCCGCAATA     GGAAGAAGAGGGCGAAGG     NC010341
  CYT-b         CATACACTATACCTCCGACAT   TCTACTGAGAAGCCACCT     NC010341
  COX-1         CATACTTTACATCCGCAACA    TCCTGTCAATCCACCCAC     NC010341
  COX-2         AACCCAGGACCTTACACCC     CCCGCAGATTTCAGAACA     NC010341
  ATP-6         TGCTGTGCCACTATGACT      ATTATTGCCACTGCGACT     NC010341
  UCP-2         CCAAAGGTCCTGCGAACA      AACCCTACTGCCAATCCC     [@B23]
  EF1α          CTTCTCAGGCTGACTGTGC     CCGCTAGCATTACCCTCC     X77689.1
                                                               

AMPKα-1, AMP-activated protein kinase α-1; AMPKα-2, AMP-activated protein kinase α-2; PGC-1β, Peroxisome proliferator activated receptor-γ coactivator-1β; NRF-1, Nuclear respiratory factor-1; TFAM, Mitochondrial transcription factor A; Mfn-1 and 2, Mitofusin-1 and 2; Opa-1, Optic atrophy-1; Drp-1, Dynamin-related protein-1; Fis-1, Fission-1; Mff, Mitochondrial fission factor; ND-1, NADH dehydrogenase-1; CYT-b, Cytochrome-b; COX-1 and 2, Cytochrome c oxidase-1 and 2; ATP-6, ATP synthase-6; UCP-2, uncoupling protein 2; EF1α, Elongation factor 1α.

Statistical Analysis
--------------------

All results are presented as mean ± standard error of the mean (SEM). Before statistical analysis, all data were tested for the normality of distribution and homogeneity of variances among different treatments. Then, data were subjected to one-way ANOVA and Tukey's multiple tests. Differences were considered significant if a *P*-value of less than 0.05 was obtained. All the statistical analyses were done with SPSS 22.0 for Windows (SPSS Inc, Chicago, IL, United States).

Results
=======

Growth Performance
------------------

Growth performances of blunt snout bream are shown in **Table [3](#T3){ref-type="table"}**. During a 12-week feeding trial, no mortality was observed among all the groups. The final weights (FWs), weight gain rate (WGR), specific growth rate (SGR), relative feed intake (RFI), feed conversion ratio (FCR), and hepatosomatic index (HIS) of fish fed the HC diet were all lower than that of the C group, but significant differences were observed in FW, RFI, and FCR (*P* \< 0.05). Additionally, FW, WGR, and SGR all increased significantly (*P* \< 0.05) as benfotiamine levels increased from 0 to 1.425 mg/kg, but decreased with further increasing levels. However, both RFI and FCR showed an opposite trend, but no significant difference (*P* \> 0.05), with the minimum value observed in fish fed the HCB2 diet. Moreover, benfotiamine supplementation further increased HIS.

###### 

Growth performance of blunt snout bream fed different experimental diets^∗^.

  Parameters   Diets                                                                                                
  ------------ ------------------- ------------------- ------------------- ------------------- -------------------- -------------------
  IW           46.38 ± 0.63        45.17 ± 0.72        44.81 ± 0.78        47.15 ± 1.11        43.11 ± 1.32         44.79 ± 0.64
  FW           167.76 ± 9.54^b^    140.53 ± 9.36^d^    152.62 ± 7.61^c^    185.08 ± 7.75^a^    129.71 ± 8.45^e^     120.30 ± 8.81^e^
  WGR †        241.71 ± 6.49^ab^   218.19 ± 9.72^bc^   232.84 ± 7.77^ab^   262.03 ± 11.11^a^   218.10 ± 12.41^bc^   195.20 ± 10.86^c^
  SGR §        1.46 ± 0.02^ab^     1.38 ± 0.03^bc^     1.43 ± 0.03^ab^     1.53 ± 0.02^a^      1.38 ± 0.02^bc^      1.29 ± 0.05^c^
  RFI \|\|     2.46 ± 0.03^a^      2.00 ± 0.09^b^      1.96 ± 0.07^b^      1.90 ± 0.07^b^      1.94 ± 0.09^b^       1.99 ± 0.05^b^
  FCR ¶        1.89 ± 0.03^a^      1.61 ± 0.08^bc^     1.53 ± 0.05^bc^     1.41 ± 0.04^c^      1.57 ± 0.07^bc^      1.70 ± 0.06^ab^
  HSI ††       1.06 ± 0.07         1.15 ± 0.11         1.21 ± 0.15         1.23 ± 0.16         1.21 ± 0.19          1.23 ± 0.12
                                                                                                                    

IW, Initial weights; FW, Final weights.
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Values are means ± SEM of four replications. Values in the same line with superscripts are significantly different (
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Feed conversion ratio (FCR) = Feed consumption (g)/fish weight gain (g).

††

Hepatosomatic index (HSI, %) = liver weight (g) × 100/body weight (g).

Plasma Metabolites, Tissue Glycogen and Lipid Contents, and Liver Biochemistry Parameters
-----------------------------------------------------------------------------------------

As can be seen from **Table [4](#T4){ref-type="table"}** and **Figure [1](#F1){ref-type="fig"}**, plasma glucose, GSP, AGES and insulin levels, ATP and AMP contents and ATP/AMP ratio as well as liver and muscle tissue glycogen and lipid contents of fish fed the HC diet were all significantly (*P* \< 0.05) higher than that of the C group. As for the HC groups, the supplementation of benfotiamine led to a significant (*P* \< 0.05) increase of plasma insulin levels, tissue glycogen and lipid contents and AMP contents, whereas the opposite was true for plasma glucose, GSP and AGES levels, and ATP contents and the ATP/AMP ratio.

###### 

Plasma metabolites and tissue glycogen and lipid contents of blunt snout bream fed different experimental diets^∗^.

  Parameters                                                          Diets              *P*-value                                                
  ------------------------------------------------------------------- ------------------ ------------------ ------------------ ------------------ --------
  Glucose (mmol/L)                                                    3.13 ± 0.02^b^     5.32 ± 0.11^a^     3.31 ± 0.02^b^     3.11 ± 0.13^b^     \<0.05
  GSP (mmol/L)                                                        14.32 ± 0.12^b^    21.02 ± 0.13^a^    13.27 ± 0.03^bc^   12.76 ± 0.06^bc^   \<0.05
  AGEs (ng/mL)                                                        3.46 ± 0.03^b^     4.89 ± 0.04^a^     3.31 ± 0.01^b^     3.34 ± 0.02^b^     \<0.05
  Insulin (ng/mL)                                                     42.31 ± 0.54^c^    73.20 ± 0.82^b^    96.57 ± 0.61^a^    98.19 ± 0.91^a^    \<0.05
  **Tissue glycogen contents (*μmol glycosyl units/g wet tissue*)**                                                                               
  Liver                                                               14.31 ± 0.38^c^    23.32 ± 0.30^b^    45.81 ± 0.34^a^    40.44 ± 0.23^a^    \<0.05
  Muscle                                                              2.46 ± 0.03^c^     3.23 ± 0.02^b^     3.67 ± 0.03^a^     3.81 ± 0.02^a^     \<0.05
  Adipose tissue                                                      1.42 ± 0.04^b^     1.79 ± 0.15^ab^    2.12 ± 0.07^a^     2.05 ± 0.01^a^     \<0.05
  **Tissue lipid contents (*percentage of wet weight*)**                                                                                          
  Liver                                                               5.92 ± 0.02^c^     7.54 ± 0.03^b^     8.86 ± 0.08^a^     8.72 ± 0.05^a^     \<0.05
  Muscle                                                              5.42 ± 0.32^c^     7.22 ± 0.11^b^     7.55 ± 0.21^b^     9.13 ± 0.45^a^     \<0.05
  Adipose tissue                                                      76.03 ± 0.41^ab^   81.21 ± 0.15^ab^   85.23 ± 0.20^a^    84.58 ± 0.19^a^    \<0.05
                                                                                                                                                  

GSP, glycated serum protein; AGEs, advanced glycation end products.

∗

Values are means ± SEM of four replications. Values in the same line with superscripts are significantly different (

P

\< 0.05).

![Hepatic ATP **(A)** and AMP **(B)** contents and the ATP/AMP ratio **(C)** of blunt snout bream fed different experimental diets. Each data represent the means ± SEM of four replicates. Bars assigned with different superscripts are significantly different (*P* \< 0.05). ATP, adenosine triphosphate; AMP, adenosine monophosphate.](fphys-09-01079-g001){#F1}

Hepatic Protein Expressions of AMPKα, PGC-1β, and NRF-1
-------------------------------------------------------

As can be seen from **Figure [2](#F2){ref-type="fig"}**, fish fed the HC diet had significantly (*P* \< 0.05) lower *p*-AMPKα/*t*-AMPKα ratio and PGC-1β protein expressions than that of the C group. As for the HC groups, the supplementation of benfotiamine significantly increased (*P* \< 0.05) the *p*-AMPKα/*t*-AMPKα ratio and PGC-1β protein expression, while little difference (*P* \> 0.05) was observed in the NRF-1 content.

![The protein expressions of AMPKα **(A)**, PGC-1β **(B)**, and NRF-1 **(C)** in the liver of blunt snout bream fed different experimental diets. Two blots were presented for each treatment. Gels were loaded with 20 μg total protein per lane. Each data represent the means ± SEM of four biological replicates. Bars assigned with different superscripts are significantly different (*P* \< 0.05).](fphys-09-01079-g002){#F2}

Hepatic Transcriptions of the Genes Involved in Mitochondrial Biogenesis
------------------------------------------------------------------------

As can be seen from **Figure [3](#F3){ref-type="fig"}**, no statistical difference (*P* \> 0.05) was observed in the transcriptions of AMPKα-1 and Mfn-2 among all the treatments. Fish fed the HC diet had significantly (*P* \< 0.05) higher transcriptional levels of AMPKα-2, Drp-1, Fis-1, and Mff than that of the C group, whereas the opposite was true for PGC-1β expression. As for the HC groups, the supplementation of benfotiamine significantly increased (*P* \< 0.05) the transcriptional levels of AMPKα-2, PGC-1β, NRF-1, TFAM, Mfn-1, and Opa-1 (with the maximum values all observed in fish fed the HCB2 diet), whereas the opposite was true for Drp-1, Fis-1, and Mff.

![The relative transcriptions of mitochondrial biogenesis-related genes in the liver of blunt snout bream fed different diets. The transcriptional levels of AMP-activated protein kinase α-1 and 2 (AMPKα-1 and 2) **(A,B)**, Peroxisome proliferator activated receptor-γ coactivator-1β (PGC-1β) **(C)**, Nuclear respiratory factor-1 (NRF-1) **(D)**, Mitochondrial transcription factor A (TFAM) **(E)**, Mitofusin-1 and 2 (Mfn-1 and 2) **(F,G)**, Optic atrophy-1 (Opa-1) **(H)**, Dynamin-related protein-1 (Drp-1) **(I)**, Fission-1 (Fis-1) **(J)** and Mitochondrial fission factor (Mff) **(K)** were all evaluated using real-time RT-PCR. Expression levels were normalized to EF1α-expressed transcripts and are presented as fold-change against the control (C) group set to 1. Each data represent the means ± SEM of four replicates. Bars assigned with different superscripts are significantly different (*P* \< 0.05).](fphys-09-01079-g003){#F3}

Hepatic Activities of the Enzymes Involved in Mitochondrial Function
--------------------------------------------------------------------

As can be seen from **Figure [4](#F4){ref-type="fig"}**, no significant difference (*P* \> 0.05) was observed in the activities of complex II among all the treatments. Fish fed the HC diet had significantly (*P* \< 0.05) lower activities of complex I, III, and IV than that of the C group, whereas the opposite was true for complex V activities. As for the HC groups, the supplementation of benfotiamine significantly increased (*P* \< 0.05) the activities of complexes I--V, with the maximum values all observed in fish fed the HCB2 diet.

![The activities of mitochondrial respiratory chain complexes (Complex I **(A)**, II **(B)**, III **(C)**, IV **(D)** and V **(E)**) in the liver of blunt snout bream fed different experimental diets. Each data represent the means ± SEM of four replicates. Bars assigned with different superscripts are significantly different (*P* \< 0.05). Complex I: NADH--ubiquinone oxidoreductase; Complex II: Succinate--ubiquinone oxidoreductase; Complex III: Ubiquinone--ferricytochrome-c oxidoreductase; Complex IV: Cytochrome c oxidase; Complex V: F1F0--ATP synthase. They were expressed as nanomolars per minute per milligram protein.](fphys-09-01079-g004){#F4}

Hepatic Transcriptions of the Enzymes Involved in Mitochondrial Function
------------------------------------------------------------------------

As can be seen from **Figure [5](#F5){ref-type="fig"}**, no significant difference (*P* \> 0.05) was observed in the transcriptions of ND-1 and COX-1 among all the treatments. Fish fed the HC diet had significantly (*P* \< 0.05) lower transcriptional level of CYT-b than that of the C group, whereas the opposite was true for ATP-6 and UCP-2 expression. As for the HC groups, the supplementation of benfotiamine significantly increased (*P* \< 0.05) the mRNA levels of CYT-b, COX-2, and ATP-6, with the maximum values all observed in fish fed the HCB2 diet.

![The relative transcriptions of mitochondrial function-related genes in the liver of blunt snout bream fed different diets. The transcriptional levels of NADH dehydrogenase-1 (ND-1) **(A)**, Cytochrome-b (CYT-b) **(B)**, Cytochrome c oxidase-1 and 2 (COX-1 and 2) **(C,D)**, ATP synthase-6 (ATP-6) **(E)**, and Uncoupling protein 2 (UCP-2) **(F)** were all evaluated using real-time RT-PCR. Expression levels were normalized to EF1α-expressed transcripts and are presented as fold-change against the control (C) group set to 1. Each data represent the means ± SEM of four replicates. Bars assigned with different superscripts are significantly different (*P* \< 0.05).](fphys-09-01079-g005){#F5}

Discussion
==========

In the present study, HC intake led to a decreased value of FW, WGR, SGR, RFI, and FCR in blunt snout bream, but HSI is on the opposite trend. This result is consistent with the fact that high-energy diets easily reduce feed palatability, and usually accelerate animal satiety, thereby, leading to low feed consumption ([@B1]). Moreover, high dietary carbohydrates usually results in persistent hyperglycemia, which is regarded as a physiological stress response, retarding the growth of fish ([@B28]). As for the HIS, it showed similar trends as the results of liver glycogen and lipid contents although no statistical difference was observed, which is similar to the results of our previous study ([@B74]). This may be ascribed to the fact that as a herbivorous species, blunt snout bream has higher glucose tolerance, which can quickly remove excessive glycogen and lipid from the liver. In addition, FW, WGR, and SGR were significantly improved by benfotiamine supplementation with increasing level up to 1.425 mg/kg, while the opposite was observed in RFI and FCR. These findings suggested a beneficial effect of benfotiamine on the growth performance of fish fed the HC diet at a suitable dosage (namely 1.425 mg/kg). According to a previous study, adequate thiamine (the analog of benfotiamine) levels could promote the activities of intestinal digestive and brush border enzymes of fish, thus improving nutrients absorption and feed efficiency, and this might promote the growth performance ([@B32]). In addition, benfotiamine administration could also diminish the hyperglycemic damage in mammals through the inhibition of AGEs formation and other metabolic pathways ([@B25]). It is possible that a similar mechanism also exists in fish. However, further studies are warranted to elucidate these facts. Together, these effects might be beneficial to the glucose homeostasis of fish fed carbohydrate-enriched diets, thereby, improving the carbohydrate utilization by fish. In addition, benfotiamine supplementation further increased the HIS, but with no significant difference, indicating benfotiamine can accelerate the removal of excessive nutrients deposited in the liver. This result is also beneficial for enhancing liver metabolic function, since the excessive accumulation of nutrients will result in histological and pathological damage of the liver ([@B31]; [@B9]). Meanwhile, the HCB3 diet led to a decrease of FW, WGR, RFI, and FCR compared with the HC group. This showed similar trends to the results of our previous work ([@B74]), although no statistical difference was observed here. Generally, this difference may be ascribed to the following differences between the previous and the current study, which might include the initial body size of fish, the stocking density, the feed consumption, the coefficient variation of the data collected within each treatment, the water temperature during the feeding trial, and so on. Furthermore, both the WGR and SGR decreased significantly with further increasing benfotiamine levels, indicating that the overdose of this substance could impair the growth performance of fish. The physiological basis for such growth retardation is still absent in fish until now. To further characterize the underlying mechanisms, molecular investigations were conducted in certain groups (namely the C, HC, HCB2, and HCB3).

In this study, fish fed the HC diet exhibited relatively high values of plasma glucose, GSP, AGES, and insulin as well as tissue glycogen and lipid compared with the control group. This suggested that high dietary carbohydrate intake induced a hyperglycemic state of fish. It is generally acknowledged that high glucose levels induced by HC intake usually stimulate the synthesis and release of insulin, thus accelerating glucose disposal in peripheral insulin target tissues by enhancing glycolysis and glycogenesis ([@B55]; [@B36]). Meanwhile, the elevated intracellular glucose levels also enhanced the Maillard reaction, thereby, increasing AGES levels ([@B3]). In addition, the results of GSP, an accurate and easily detectable intermediate marker of glycemia, in this study, further supported the afore-mentioned facts ([@B66]). The enhanced tissue glycogen and lipid deposition is also justifiable, since HC intake generally promotes the glycogenesis and lipogenesis of fish ([@B16]). In addition, dietary supplementation of benfotiamine further increased plasma insulin levels and tissue glycogen and lipid content, whereas the opposite was true for plasma glucose, GSP, and AGES levels. These results suggested that benfotiamine could improve the glucose homeostasis of blunt snout bream fed a HC diet. This may be due to the following facts: (1) benfotiamine could stimulate insulin synthesis by improving the function of pancreatic β-cells, thus resulting in low plasma glucose and GSP levels ([@B59]); (2) benfotiamine could accelerate the removal of intracellular glycerhaldeyde-3-phosphate (G3P), thereby decreasing the formation of AGES ([@B3]); and (3) benfotiamine could enhance the pentose phosphate pathway and fatty acid synthesis, thus increasing lipid accumulation ([@B4]; [@B3]). However, these are the cases for mammals. Whether fish show a similar mechanism is still uncertain, and this warrants further study. Meanwhile, the elevated insulin levels usually enhance the activities of glycogen synthase (GSase) and the dephosphorylation of glycogen phosphorylase (GPase), which might promote glycogen storage in tissues in fish ([@B50]).

Generally, ATP is the major energy "currency" in cells, and the ATP/AMP ratio is a sensitive indicator of the alterations of the energy status ([@B78]). In the present study, the hepatic ATP and AMP contents and ATP/AMP ratio of fish fed the HC diet were all significantly higher than that of the control group. The most plausible explanation would be that high dietary carbohydrate intake usually elevates the energy state of cells, thus increasing ATP contents ([@B64]). The excessive ATP was hydrolyzed consequently, thus leading to the increased AMP content. Moreover, dietary benfotiamine supplementation led to the increased AMP contents, while the opposite was true for ATP contents and the ATP/AMP ratio. This indicated that benfotiamine could modify the intracellular energy state of fish. According to a previous study, as a thiamin analog, benfotiamine could accelerate ATP hydrolysis via the following reaction: thiamine + ATP →thiamine diphosphate (ThDP) + AMP, thereby decreasing the ATP/AMP ratio ([@B47]). In addition, the decreased ATP/AMP ratio by benfotiamine administration is regarded as a positive signal for glucose homeostasis, since it could activate some specific energy sensors (such as AMPK), thereby coordinating the glycolipid metabolism of fish ([@B63]).

Current studies have demonstrated that mitochondrial fusion and fission processes play a prominent role in the modulation of mitochondrial biogenesis and function ([@B61]; [@B67]). Additionally, mitochondrial fusion and fission enzymes have also attracted considerable attention due to their critical roles in controlling the dynamic events mentioned earlier ([@B67]). However, such information in fish is still barely understood. In this study, hepatic transcriptions of AMPKα-1, Drp-1, Fis-1, and Mff were all upregulated by the intake of carbohydrate-rich diets compared with the control group, whereas the opposite was true for PGC-1β and NRF-1 transcriptions as well as PGC-1β and NRF-1 protein expressions and the *p*-AMPKα/*t*-AMPKα ratio. According to previous studies, the increased intracellular ATP contents by HC intake usually inhibit the activity of AMPK in fish ([@B53],[@B54]). Subsequently, the inactive AMPK could weaken mitochondrial biogenesis signals by reducing the activity of the PGC-1/NRF-1 pathway, resulting in a decrease of mitochondrial content in cells ([@B79]). Meanwhile, excessive carbohydrate intake also amplifies mitochondrial oxidative stress by increasing the generation of intracellular reactive oxygen species (ROS), thereby accelerating mitochondrial fission characterized by the upregulation of related genes (namely Drp-1, Fis-1, and Mff) ([@B81]). In addition, dietary supplementation of benfotiamine at 1.425 mg/kg significantly upregulated the transcriptions of AMPKα-2, PGC-1β, NRF-1, TFAM, Mfn-1, and Opa-1, the protein contents of PGC-1β as well as the *p*-AMPKα/*t*-AMPKα ratio, whereas the opposite was true for Drp-1, Fis-1, and Mff. These results indicated that a long-term administration of benfotiamine at the appropriate dosages effectively enhanced the mitochondrial biosynthesis of fish fed the HC diet. According to a previous study, benfotiamine could decrease the ATP/AMP ratio by accelerating ATP hydrolysis, thereby increasing the activity of AMPK ([@B47]). Once activated, AMPK conveys its signals to induce mitochondrial biogenesis via targeting the PGC-1β/NRF-1 pathway that regulates mtDNA replication and expression ([@B72]). Furthermore, these results were further supported by the fact that AMPK activation can prevent high glucose-induced mitochondrial fission by inhibiting the activity of the proteins involved in mitochondrial fission (such as Drp-1 and Mff), thus coordinating this organelle shape and function ([@B71]; [@B15]; [@B12]). It should be stated here that this information was mainly derived from mammals. The underlying mechanisms in fish still need further in-depth studies. Nevertheless, the enhanced mitochondrial biogenesis by benfotiamine may be helpful for the maintenance of glucose homeostasis in this fish, thus improving its carbohydrate utilization.

Mitochondrion is the main site of energy production in cells, and responsible for the production of ATP for the basic activities of life ([@B70]). Generally, ATP synthesis in mitochondria depends on the oxidative phosphorylation (OXPHOS) by means of an enzyme pathway consisting of five multisubunit enzyme complexes located within the mitochondrial inner membrane ([@B69]). Therefore, investigations of these enzyme complexes will facilitate our understanding of the mitochondrial function. In the present study, the hepatic complexes I--IV activities of fish fed the HC diet were all significantly lower than that of the control group, whereas the opposite was true for the activities of complex V. These results might be attributed to the fact that the oxidative stress induced by HC intake would cause mitochondrial damage, then leading to the decreases in mitochondrial respiratory enzyme activities ([@B41]; [@B44]). As for the increased complex V activities, it might be a result of the increased energy intake by fish due to HC feeding, which is in line with the trend of ATP content. This is due to the fact that complex V (ATP synthase) is the last rate-limiting enzyme in ATP synthesis, driving the phosphorylation of ADP to ATP ([@B69]; [@B68]). These trends were supported by the fact that high energy consumption generally causes the mitochondria to increase oxidative phosphorylation rate and ATP production ([@B35]), thereby enhancing the activities of complex V (namely the ATP synthase) ([@B27]). Similar results were also reported in rainbow trout (*Oncorhynchus mykiss*) ([@B19]) and channel catfish (*Ictalurus punctatus*) ([@B35]). Moreover, dietary benfotiamine supplementation led to the increased complexes I--V activities. This indicated that benfotiamine could enhance mitochondrial function of fish. According to a previous study, benfotiamine could prevent mitochondria from oxidative stress by scavenging free radicals and inhibiting oxidants production, thus enhancing the mitochondrial respiratory enzyme activities ([@B45]). Furthermore, a previous study investigating the effects of the B vitamin family on mitochondrial function further supported this by demonstrating that vitamin B~1~ is an important cofactor for various mitochondrial enzyme complexes ([@B14]). Meanwhile, we further evaluated the mitochondrial function by detecting the transcriptional levels of related genes. The transcription of CYT-b in liver decreased remarkably with increasing dietary carbohydrate levels, whereas the opposite was true for ATP-6 expression. In addition, the transcripts of ND-1, COX-1, and COX-2 were all downregulated by the HC diet, although no significance was detected. These results were in accordance with that of the mitochondrial complexes activities, suggesting that a long-term intake of the HC diet could result in an impaired mitochondrial function in this fish. This was supported by the fact that the decreased expressions of ND-1, CYT-b, COX-1, and COX-2 might affect the assembly of mitochondrial complexes, then reducing the catalytic ability of OXPHOS ([@B18]; [@B70]). Furthermore, the excessive production of ROS resulting due to the HC intake would also accelerate mitochondrial fission, which might, in turn, depress the transcriptions of these genes ([@B58]; [@B81]). The upregulated ATP-6 expression might be attributed to the increased energy intake caused by HC diets, which could increase the oxidative phosphorylation rate and ATP production in mitochondria, then enhancing its transcriptional level ([@B35]). Here, an increased UCP-2 expression was also found in the HC group, suggesting that HC intake induced the uncoupling reaction in the respiratory chain. This phenomenon seems to be the opposite of ATP content, but it is not unique to our system. Infact, previous studies have confirmed that high-sucrose diet intake could also accelerate the phosphorylation of ADP to produce ATP by stimulating the coupling reaction in liver mitochondria despite the overexpression of UCP ([@B62]). These results may suggest that the expression of UCPs and mitochondrial respiration are not completely interconnected ([@B29]; [@B62]). However, the underlying mechanisms involving these aspects mentioned previously are still unknown. Meanwhile, dietary supplementation of benfotiamine at 1.425 mg/kg resulted in a remarkable increase of the transcriptions of CYT-b, COX-2, and ATP-6. This result indicated an enhanced mitochondrial function in the liver of blunt snout bream due to the administration of benfotiamine at suitable dosages. This was further supported by the fact that benfotiamine could scavenge excess free radicals as well as inhibit superoxide anion production, thus alleviating the functional damage of mitochondria caused by high glucose-induced oxidative stress ([@B45]). The studies afore-mentioned are mainly focused on mammals. The exact mechanisms in fish still warrant further in-depth studies.

In summary, the findings of the present study indicated that dietary supplementation of benfotiamine could improve the growth performance and mitochondrial biogenesis and function of *M. amblycephala* fed HC diets, through the activation of the AMPK/PGC-1β/NRF-1 pathway, the upregulation of the fusion-associated genes, and the enhancement of mitochondrial enzyme complexes activities as well as their transcriptions. The best value of growth performance and mitochondrial biogenesis and function were all observed in fish offered 1.425 mg/kg benfotiamine.
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